Vetoquinol’s Acquisition of 90% Stake in Clarion Biociências


Trench Rossi Watanabe (Baker McKenzie) and Cescon, Barrieu, Flesch & Barreto advised on the deal

Vetoquinol Saúde Animal Ltda., operating as a subsidiary of Vetoquinol S.A., executed the acquisition of 90% stake in Clarion Biociências for an undisclosed ammount.

Founded in 1998, Clarion Biociências develops, manufactures and distributes veterinary medicine and non-medicinal products primarily targeting the livestock market. Thanks to its geographical presence at the very heart of Brazil’s bovine breeding area, the laboratory enjoys a strong market share in the bovine segment (which accounts for more than half of the Brazilian animal health market), in particular with internal and external parasiticides (Contratack®, Novatack®, Eprino, Fiprotack®, Altis). Clarion Biociências employs around 200 people, including a sales force of 70 people. The company generated net sales of over 50 million Brazilian Reais (around €12 million) in 2018. The Company has been recording a solid growth for over three years, fueled by the success of the launches of differentiated products and the strengthening of its sales team. Sales are expected to show a strong performance this year again.

With this acquisition, the Vetoquinol Group significantly strengthens its foothold in Brazil, the world’s third largest animal health market. Vetoquinol first entered the market in 2011 with Vetoquinol Saúde Animal; the Group has since been focused on the development of its Essentials products for beef and dairy cattle, for swine and for companion animals. Clarion Biociências has a strong product pipeline close to being launched in both bovine and companion animal markets; some of these products will also be launched in the swine market in which Clarion Biociências is currently not playing; all of these promising projects together with the underlying Vetoquinol projects are expected to generate some substantial commercial synergies.

Trench Rossi Watanabe (Baker McKenzie) advised Vetoquinol Saúde Animal Ltda. with Alberto Mori (Picture) and Paula Senna Ganem.

Cescon, Barrieu, Flesch & Barreto advised Clarion Biociências with Fernando de Melo Gomes, Juliana Vianna Lacreta Gobbi, Mariana Miranda Perecin, Maria Luiza Junqueira Oliveira de Barros and Marina Carvalho Faro.

Involved fees earner: Marina Carvalho Faro – Cescon, Barrieu, Flesch & Barreto; Fernando De Melo Gomes – Cescon, Barrieu, Flesch & Barreto; Juliana Vianna Lacreta Gobbi – Cescon, Barrieu, Flesch & Barreto; Mariana Miranda Perecin – Demarest; María Luiza Junqueira Oliveira de Barros – Machado Meyer Advogados; Alberto Mori – Trench, Rossi and Watanabe Advogados;

Law Firms: Cescon, Barrieu, Flesch & Barreto; Demarest; Machado Meyer Advogados; Trench, Rossi and Watanabe Advogados;

Clients: Clarion Biociências Ltda.; Vetoquinol Saúde Animal Ltda.;